A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Merck Sharp & Dohme LLC
Pfizer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
SCRI Development Innovations, LLC
Pfizer
Roswell Park Cancer Institute
Baylor Research Institute
Institut du Cancer de Montpellier - Val d'Aurelle
Gruppo Oncologico del Nord-Ovest